129 related articles for article (PubMed ID: 16114171)
1. Virucidal activity of Virkon S on human enterovirus.
Chan YF; Abu Bakar S
Med J Malaysia; 2005 Jun; 60(2):246-8. PubMed ID: 16114171
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of adenovirus types 5 and 6 by Virkon S.
McCormick L; Maheshwari G
Antiviral Res; 2004 Oct; 64(1):27-33. PubMed ID: 15451176
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of alcohols and alcohol-based hand disinfectants against human enterovirus 71.
Chang SC; Li WC; Huang KY; Huang YC; Chiu CH; Chen CJ; Hsieh YC; Kuo CY; Shih SR; Lin TY
J Hosp Infect; 2013 Apr; 83(4):288-93. PubMed ID: 23399482
[TBL] [Abstract][Full Text] [Related]
4. Assessment of in-vitro efficacy of 1% Virkon against bacteria, fungi, viruses and spores by means of AFNOR guidelines.
Herńndez A; Martró E; Matas L; Martín M; Ausina V
J Hosp Infect; 2000 Nov; 46(3):203-9. PubMed ID: 11073729
[TBL] [Abstract][Full Text] [Related]
5. The action of VIRKON No Foam on the hepatitis B virus.
Scioli D; Pizzella T; Vollaro L; Nardiello S; De Feo L
Eur J Epidemiol; 1997 Dec; 13(8):879-83. PubMed ID: 9476816
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of in vitro efficacy of the disinfectant Virkon.
Gasparini R; Pozzi T; Magnelli R; Fatighenti D; Giotti E; Poliseno G; Pratelli M; Severini R; Bonanni P; De Feo L
Eur J Epidemiol; 1995 Apr; 11(2):193-7. PubMed ID: 7672075
[TBL] [Abstract][Full Text] [Related]
7. Aquaculture fouling: Efficacy of potassium monopersulphonate triple salt based disinfectant (Virkon® Aquatic) against Ciona intestinalis.
Paetzold SC; Davidson J
Biofouling; 2011 Jul; 27(6):655-65. PubMed ID: 21722037
[TBL] [Abstract][Full Text] [Related]
8. Smart Card Decontamination in a High-Containment Laboratory.
Gabbert LR; Smith JD; Neilan JG; Ferman GS; Rasmussen MV
Health Secur; 2018; 16(4):244-251. PubMed ID: 30096256
[TBL] [Abstract][Full Text] [Related]
9. [Irritating effect and dermal toxicity of virkon, a disinfectant widely used in Poland].
Krysiak B; Stetkiewicz J; Kieć-Swierczyńska M
Med Pr; 2000; 51(5):457-63. PubMed ID: 11199175
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of human enterovirus 71 and coxsackie virus A16 and hand, foot, and mouth disease.
Kadurugamuwa JL; Shaheen E
Am J Infect Control; 2011 Nov; 39(9):788-9. PubMed ID: 21565426
[TBL] [Abstract][Full Text] [Related]
11. [Virucidal efficacy of a chemical instrument surface disinfectant ("Gigasept") against coxsackie virus type B3. II. Investigation in the instrumental surface test (author's transl)].
Thraenhart O; Kuwert E
Zentralbl Bakteriol Orig B; 1977 Jan; 164(1-2):22-44. PubMed ID: 842188
[TBL] [Abstract][Full Text] [Related]
12. The effect of Virkon S fogging on survival of Salmonella enterica and Staphylococcus aureus on surfaces in a veterinary teaching hospital.
Dunowska M; Morley PS; Hyatt DR
Vet Microbiol; 2005 Feb; 105(3-4):281-9. PubMed ID: 15708826
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of the antiviral activity of the disinfectant VIRKON].
Bonfanti C; Pollara P; De Rango C; Turano A
Ann Ig; 1995; 7(1):55-62. PubMed ID: 8663967
[No Abstract] [Full Text] [Related]
14. [Evaluation of allergic sensitivity to the virkon disinfectant preparation widely used in Poland].
Krysiak B; Stetkiewicz J; Kieć-Swierczyńska M
Med Pr; 2000; 51(6):603-8. PubMed ID: 11288688
[TBL] [Abstract][Full Text] [Related]
15. A membrane-based quantitative carrier test to assess the virucidal activity of disinfectants and persistence of viruses on porous fomites.
Mocé-Llivina L; Papageorgiou GT; Jofre J
J Virol Methods; 2006 Jul; 135(1):49-55. PubMed ID: 16563525
[TBL] [Abstract][Full Text] [Related]
16. Tuberculocidal activity of a peroxymonosulphate-based disinfectant-detergent (Virkon).
De Lorenzi S; Finzi G; Mosca B; Salvatorelli G
J Hosp Infect; 2008 Jan; 68(1):96-7. PubMed ID: 18069085
[No Abstract] [Full Text] [Related]
17. Virucidal activity of a quaternary ammonium compound disinfectant against feline calicivirus: a surrogate for norovirus.
Jimenez L; Chiang M
Am J Infect Control; 2006 Jun; 34(5):269-73. PubMed ID: 16765204
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of infectious bursal disease and Newcastle disease viruses at temperatures below 0 C using chemical disinfectants.
Guan J; Chan M; Brooks BW; Rohonczy L
Avian Dis; 2014 Jun; 58(2):249-54. PubMed ID: 25055629
[TBL] [Abstract][Full Text] [Related]
19. [Examination of biocides for their effectiveness against animal viruses according to European Union Standards with emphasis on the selection of a suitable test virus].
Al-Khleif A; Baljer G; Herbst W
Berl Munch Tierarztl Wochenschr; 2009; 122(1-2):58-62. PubMed ID: 19226936
[TBL] [Abstract][Full Text] [Related]
20. Towards the design of combination therapy for the treatment of enterovirus infections.
Thibaut HJ; Leyssen P; Puerstinger G; Muigg A; Neyts J; De Palma AM
Antiviral Res; 2011 Jun; 90(3):213-7. PubMed ID: 21466823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
